Novavax
American biotechnology company
Novavax ▸ Facts ▸ Comments ▸ News ▸ Videos
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.
| 0 shares | ShareTweetSavePostSend |
You Might Like
WHO approves SII's Covovax for emergency useCovavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children.DNA - Published | |
Novavax Covid-19 vaccine receives first emergency use authorizationNovavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in Indonesia, making it the first approval anywhere in the world for..IndiaTimes - Published | |
Novavax trials to include kids from 7 to 11IndiaTimes - Published | |
Novavax vaccine efficacy data promising, encouraging: GovtIndiaTimes - Published | |
COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacyNovavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.DNA - Published | |
US to ease Covid vaccine input supply: Kamala Harris to PM ModiUS Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..IndiaTimes - Published | |
